Patent Assignment
Reel/Frame 058746/0736
Assignment of Assignor's Interest
Recorded: 2022-01-24
Pages: 9
Assignors
HANLEY, DAVID CHRISTIAN
Executed: 2019-08-02
YOCCA, FRANK
Executed: 2019-08-02
LATHIA, CHETAN DALPATBHAI
Executed: 2019-08-02
Assignee
BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, 5TH FLOOR, NEW HAVEN, CONNECTICUT, 06511
Covered Property
(1)
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 24, 2022
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 058746/0778 →
Assignment of Assignor's Interest
Jan 24, 2022
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 058746/0813 →
Assignment of Assignor's Interest
Jan 24, 2022
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 058829/0239 →
Security Interest
Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059726/0788 →
Security Interest
Apr 19, 2022
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 059727/0964 →
Assignment of Assignor's Interest
May 30, 2023
From: ARX, LLC
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 063789/0539 →
Corrective Assignment to Correct the Property Numbers and Remove Application Number 17/579,914 and Application Number 18/085,263 Previously Recorded at Reel: 063789 Frame: 0539. Assignor(S) Hereby Confirms the Assignment.
Jun 7, 2023
From: ARX, LLC
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 064042/0592 →
Security Interest
Sep 11, 2024
From: BIOXCEL THERAPEUTICS, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 068938/0906 →